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Oral Hormone therapy undesirable effects description on Hospital Fernando
Fonseca breast cancer patients and identification of the measures taken by
patients on those circumstances.
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Up untill January 2011, 269 patients engage in this survey. 151 were on
tamoxifen therapy, 34 patients on Anastrozole therapy, 53 patients had
letrozole as breast cancer hormone tharapy and 31 patients were on
exemestan therapy.
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Graphic 7: Undesirable effects proportion (%) pointed out by Exemestan patients
0
20
40
60
80
100
Hot Flashes Increased 
sweating
Dizziness Fatigue Nausea 
Vomiting
Headache Insomnia Joint Pain Hair loss Decreased 
Appetite
Graphic 8: Actions taken by Exemestan patients
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Graphic 1: Undesirable effects proportion  (%)  pointed out by Tamoxifen  patients
0,0
20,0
40,0
60,0
80,0
100,0
Hot  Flashes Vaginal 
Bleeding
Vaginal 
Discharge
Vaginal 
Itching
Stomach 
Upset
Headache Dizziness Water 
Retention
Hair loss
Graphic 2: Actions taken by Tamoxifen patients
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Graphic 3: Undesirable effects proportion  (%)  pointed out  by Anastrozol patients
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Graphic 4: Actions taken by Anastrozol patients
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Graphic 5: Undesirable Effects proportion  (%) pointed out  by Letrozol patients
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Graphic 6: Actions taken by Letrozol patients
None Health professional Self medication Prescribed medication
